<DOC>
	<DOCNO>NCT02798510</DOCNO>
	<brief_summary>The present study design determine whether adjuvant concurrent chemoradiotherapy improve overall survival .</brief_summary>
	<brief_title>Clinical Trial Adjuvant Chemotherapy Followed Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone Patients With Gallbladder Carcinoma Extrahepatic Cholangiocarcinoma</brief_title>
	<detailed_description>The role adjuvant radiotherapy gallbladder carcinoma ( GBCA ) extrahepatic cholangiocarcinoma ( EHCC ) unknown . A retrospective study suggest chemoradiotherapy provide great benefit chemotherapy alone GBCA patient . SWOG S0809 , phase II study show adjuvant chemoradiotherapy promise efficacy GBCA EHCC . The present phase III clinical trial design compare adjuvant concurrent chemoradiotherapy chemotherapy alone .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>The patient pathologic diagnosis gallbladder carcinoma ( GBCA ) extrahepatic cholangiocarcinoma ( EHCC ) radical resection . The patient pathologic stage T24 N1 R0 resection positive resection margin ( R1 ) . Aged 18 70 year old , male female , body condition score generally ECOG 0～2 , expect survival ≥ 6 month . Subjects major organ dysfunction , blood , liver , kidney heart function normal , specific requirement laboratory indicator : Blood : Absolute neutrophil count &gt; 1.5 × 109 / L , Platelet count &gt; 100 × 109 / L , Hb &gt; 8.0g/dl . Liver function : serum bilirubin le 1.5 time upper limit normal ; ALT AST less 2.5 time upper limit normal . Renal function : creatinine le 1.5 time upper limit normal . Patients understand circumstance study sign informed consent . Pregnancy , breastfeed patients； Patients receive prior anticancer therapy current malignancy upper abdominal radiotherapy chemotherapy time . Patients malignant ascites . Patients purulent chronic infect wound delay heal . Patients liver , kidney heart failure coronary heart disease , angina , myocardial infarction , arrhythmia , cerebral thrombosis , stroke serious cardiovascular cerebrovascular disease ; Patients history mental illness difficult control ; Patients consider inappropriate participate trial researcher .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Gallbladder Carcinoma</keyword>
	<keyword>Extrahepatic Cholangiocarcinoma</keyword>
	<keyword>Chemoradiotherapy</keyword>
</DOC>